Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
WITHDRAWN
Clinical Phase
NA
Study Classification
INTERVENTIONAL
Study Start Date
2018-09-30
Study Completion Date
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients diagnosed with chronic SIJ pain that can be treated by sacroiliac joint fusion or radiofrequency ablation. The radio frequency ablation is performed using either conventional or "cooled" techniques aimed at the S1-S3 lateral branches and the L5 dorsal ramus. Minimally invasive sacroiliac joint consists of implanting 2 to 3 metallic implants inside the SIJ to increase the stability and eventually fuse the SIJ. This randomized controlled trial aims at comparing treatment success at 6-month follow-up time-point after minimally invasive sacroiliac joint fusion and radiofrequency ablation for chronic SIJ dysfunction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1
NCT06909292
Sacroiliac Joint Dysfunction
RECRUITING
Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK
NCT01861899
Joint Dysfunction
COMPLETED
Sacroiliac Joint Fusion With iFuse Implant System (SIFI)
NCT01640353
Degenerative Sacroiliitis
Sacroiliac Joint Disruption
COMPLETED
Post-Market Clinical Study on a Modular SI Joint Fusion System
NCT05916092
Sacroiliitis
Sacroiliac Joint Dysfunction
ENROLLING_BY_INVITATION
Investigation of Sacroiliac Fusion Treatment (INSITE)
NCT01681004
Degenerative Sacroiliitis
Sacroiliac Joint Disruption
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Introduction This document is a protocol for a human research study. This study is to be conducted according to US and international standards of Good Clinical Practice (FDA Title 21 part 312 and International Conference on Harmonization guidelines), applicable government regulations and Institutional research policies and procedures.
Background
Sacroiliac joint (SIJ) dysfunction is a common pain condition involving the buttock and may irradiate in the low back, groin and/or lower extremity. About one in five patients with low back pain is estimated to have SI joint pain. The economic burden of SIJ pain is high in the United States and there is a need for more cost effective treatment options. There is a lack of relevant high quality studies that compared nonsurgical and surgical treatment for SI joint dysfunction.
Sacroiliac joint (SIJ) dysfunction has been estimated to be the origin of lower back pain in 13 to 30% of patients. SIJ pain is usually referred to the buttock, low back, groin and/or lower extremity. SIJ osteoarthritis, trauma, SIJ degeneration following lumbar fusion and postpartum SIJ dysfunction are common causes of SIJ pain found in a clinical setting. Other less common causes for SIJ pain include inflammatory sacroiliitis, infective sacroiliitis, insufficiency stress fractures and neoplasia.
Diagnostic evidences for SIJ dysfunction
The presenting symptoms of SIJ dysfunction can be similar to those of other spinal conditions such as disc herniation or degenerative spinal stenosis. Unlike radiculopathy, there is often an absence of specific radiological finding with SIJ dysfunction. A gold standard for SI joint pain diagnosis does not exist, but dual comparative local anesthetic joint blocks with at least 70% pain relief are considered a validated diagnostic test for SI joint pain. Reproducibility of SIJ pain with at least 3 SIJ-selective stressing tests, including the thigh trust, compression, Patrick's, distraction and Gaenslen's test, is also considered having good diagnostic validity.
Investigational Agents and Preclinical Data
Nonsurgical treatment efficacy for SIJ dysfunction
Sacroiliac dysfunction is thought to be secondary to a loss of SIJ stability caused by either deficient form closure (joint anatomy) or force closure (compressive forces exerted by neuromuscular and ligamentous structures around the joint. Physical therapy can improve SI joint pain by increasing force closure. Pelvic stabilization, strengthening and self-bracing exercises have been showed to improve force closure and may provide SIJ pain relief.
When SIJ pain fails to improve with physical therapy, several pain management interventions can be offered to patients. Up to now, the level of evidence for SIJ intraarticular or periarticular steroid injections is mainly limited to short-term outcome (3 months) and the effectiveness results are conflicting between different studies.
Compared to conventional radio frequency ablation, the effectiveness of cooled radiofrequency ablation is supported by superior level of evidence. Two randomized controlled trials comparing cooled radio frequency ablation vs placebo demonstrated a success rate varying between 38 to 57% at 6 months for cooled radiofrequency ablation. Observational studies also demonstrated success rate varying from 40% to 71% at 6 months for both conventional and cooled radio frequency ablation. The effectiveness of conventional and cooled radio frequency ablation at 9 and 12 months are more limited and some studies did report loss of effectiveness at 12 months. Based on the available data, there is no evidence supporting clinical superiority between traditional and cool radio frequency ablation. A retrospective study on 88 patients revealed comparable effectiveness between conventional and cool radio frequency ablation with \> 50% pain reduction in the majority of patients after 3 and 6 months.
Surgical treatment evidence for SIJ dysfunction
Minimally invasive SIJ fusion is a surgical treatment aimed at stabilizing the SIJ to reduce pain, disability and improve quality of life. In a recent randomized controlled trial called Investigation of Sacroiliac Fusion Treatment (INSITE), minimally invasive SIJ fusion, using triangular titanium implants (iFuse Implant System, SI-BONE®, San Jose, CA), has been shown superior to non-surgical treatments in managing SIJ dysfunction at 6 months (81.4% vs 26.1% success rate) and the results in the surgical group were sustained at one year and two years of follow-up. In this trial, success rate was defined as a decreased in SIJ pain Visual Analogue Score of at least 20 mm compared to baseline, an absence of device-related serious adverse events, an absence of neurological worsening and no surgical reintervention. There were 101 subjects in the SIJ fusion group who completed the 6 months follow-up.
Clinical Data to Date The INSITE study is the first and only published Level 1 randomized controlled trial to have compared SIJ fusion with nonsurgical treatment. Although this study demonstrated prolonged improvement in pain, disability and quality of life with SIJ fusion, superiority of SIJ fusion compared to nonsurgical treatment at 6 months cannot be generalized. This superiority trial may not have been truly clinically relevant because there was no specific treatment protocol used in the nonsurgical group for each subject. Nonsurgical management consisted of physical therapy in 98%, at least one steroid injection in 74%, 2 steroid injections in 4% and radiofrequency ablation of the sacral nerve root lateral branches in 46% of the 46 subjects assigned to nonsurgical treatment. The different proportions of treatment offered in the nonsurgical group may in fact differ from other pain management clinical practices and the generalizability of the results is questionable.
Compared to all nonsurgical treatment available for SIJ pain, the effectiveness of radiofrequency ablation is supported by literature of higher level of evidence. Prolonged therapeutic effect up to 6 months after the procedure has been demonstrated for radiofrequency ablation. In the INSITE study, only 21 subjects received radio frequency ablation, a group size that corresponds to only 21% of the number of subjects studied for SIJ fusion. This may explain why the nonsurgical group only had 26.1% success rate in this trial. The quality of evidence for the INSITE study may also be contested as the study sponsor, SI-BONE®, participated in the manuscript redaction and performed the statistical analysis.
The costs of nonsurgical treatments for SIJ pain are substantial in the United Sates medicare population and there is a need to assess the best cost effective therapy for SI joint pain. SIJ fusion and RFN are two SIJ pain treatment modalities that have been studied with a higher level of evidence compared to other modalities, showing significant effectiveness lasting more than 6 months after each procedure. However the effectiveness and costs associated with these two different treatments have never been compared in a clinically relevant randomized trial.
Dose Rationale and Risk/Benefits
RISKS
General / Unforeseeable
The risks of receiving a SIJ fusion include but are not limited to:
* post-operative incisional pain or worsened pain due to muscle spams
* hematoma and/or surgical site infection (less likely)
* nerve damage that can cause paralysis, loss of sensation or pain (unlikely
* possible second intervention for revision or withdrawal of implants (unlikely)
The risks of receiving SIJ radiofrequency ablation include but are not limited to:
* Pain or discomfort around the area treated
* numbness of skin covering the area treated, worsened pain due to muscle spasm,
* permanent nerve pain (less likely)
* allergies or reactions to medications, infection and/or hematoma (less likely) 3rd degree burn (rare)
* Nerve damage due to trauma (rare)
Other risks that are not specifically related to SIJ fusion or SIJ radiofrequency ablation but may occur during any procedure include:
* cardiovascular and /or cerebrovascular events
* cardiac arrhythmia
* deep vein thrombosis
* pulmonary emboli
* pneumonia
* urinary tract infection
* skin abrasions
* coma or death
Radiation Risks
Fluoroscopy is an imaging technique that uses X-rays during the SIJ fusion or SIJ radiofrequency ablation. This form or ionizing radiation poses a potential for increasing the patient's risk of radiation-induced cancer. Radiations doses and exposure during the study are the same that would be used if the subjects were receiving the treatment outside of this study. Therefore, this study does not involve any additional radiation risk for the subjects.
Study Objectives
Primary objective: Determine clinical superiority between minimally invasive SIJ fusion and radiofrequency ablation in chronic SIJ dysfunction patients
Secondary Objectives: Compare cost-effectiveness between treatment groups
Study Design
General Design
* Randomized controlled trial where randomization is done by a random number generator. Even numbers will be directed to the SI joint procedure group and odd numbers will be directed to the radiofrequency ablation procedure.
* The enrolment uses a 1:1 ratio of SIJ fusion to radio frequency ablation
* The subjects and investigators are not blinded to treatment allocation
Subjects will have a detailed medical history and will complete these questionnaires
* SIJ pain rating using the Visual Analogue Scale (VAS)
* Oswestry Disability Index (ODI)
* Short Form-36 (SF-36)
All subjects will be evaluated at randomization and at follow-up visits scheduled at 1, 3, 6, 9, and 12 months.
Background
Sacroiliac joint (SIJ) dysfunction is a common pain condition involving the buttock and may irradiate in the low back, groin and/or lower extremity. About one in five patients with low back pain is estimated to have SI joint pain. The economic burden of SIJ pain is high in the United States and there is a need for more cost effective treatment options. There is a lack of relevant high quality studies that compared nonsurgical and surgical treatment for SI joint dysfunction.
Sacroiliac joint (SIJ) dysfunction has been estimated to be the origin of lower back pain in 13 to 30% of patients. SIJ pain is usually referred to the buttock, low back, groin and/or lower extremity. SIJ osteoarthritis, trauma, SIJ degeneration following lumbar fusion and postpartum SIJ dysfunction are common causes of SIJ pain found in a clinical setting. Other less common causes for SIJ pain include inflammatory sacroiliitis, infective sacroiliitis, insufficiency stress fractures and neoplasia.
Diagnostic evidences for SIJ dysfunction
The presenting symptoms of SIJ dysfunction can be similar to those of other spinal conditions such as disc herniation or degenerative spinal stenosis. Unlike radiculopathy, there is often an absence of specific radiological finding with SIJ dysfunction. A gold standard for SI joint pain diagnosis does not exist, but dual comparative local anesthetic joint blocks with at least 70% pain relief are considered a validated diagnostic test for SI joint pain. Reproducibility of SIJ pain with at least 3 SIJ-selective stressing tests, including the thigh trust, compression, Patrick's, distraction and Gaenslen's test, is also considered having good diagnostic validity.
Investigational Agents and Preclinical Data
Nonsurgical treatment efficacy for SIJ dysfunction
Sacroiliac dysfunction is thought to be secondary to a loss of SIJ stability caused by either deficient form closure (joint anatomy) or force closure (compressive forces exerted by neuromuscular and ligamentous structures around the joint. Physical therapy can improve SI joint pain by increasing force closure. Pelvic stabilization, strengthening and self-bracing exercises have been showed to improve force closure and may provide SIJ pain relief.
When SIJ pain fails to improve with physical therapy, several pain management interventions can be offered to patients. Up to now, the level of evidence for SIJ intraarticular or periarticular steroid injections is mainly limited to short-term outcome (3 months) and the effectiveness results are conflicting between different studies.
Compared to conventional radio frequency ablation, the effectiveness of cooled radiofrequency ablation is supported by superior level of evidence. Two randomized controlled trials comparing cooled radio frequency ablation vs placebo demonstrated a success rate varying between 38 to 57% at 6 months for cooled radiofrequency ablation. Observational studies also demonstrated success rate varying from 40% to 71% at 6 months for both conventional and cooled radio frequency ablation. The effectiveness of conventional and cooled radio frequency ablation at 9 and 12 months are more limited and some studies did report loss of effectiveness at 12 months. Based on the available data, there is no evidence supporting clinical superiority between traditional and cool radio frequency ablation. A retrospective study on 88 patients revealed comparable effectiveness between conventional and cool radio frequency ablation with \> 50% pain reduction in the majority of patients after 3 and 6 months.
Surgical treatment evidence for SIJ dysfunction
Minimally invasive SIJ fusion is a surgical treatment aimed at stabilizing the SIJ to reduce pain, disability and improve quality of life. In a recent randomized controlled trial called Investigation of Sacroiliac Fusion Treatment (INSITE), minimally invasive SIJ fusion, using triangular titanium implants (iFuse Implant System, SI-BONE®, San Jose, CA), has been shown superior to non-surgical treatments in managing SIJ dysfunction at 6 months (81.4% vs 26.1% success rate) and the results in the surgical group were sustained at one year and two years of follow-up. In this trial, success rate was defined as a decreased in SIJ pain Visual Analogue Score of at least 20 mm compared to baseline, an absence of device-related serious adverse events, an absence of neurological worsening and no surgical reintervention. There were 101 subjects in the SIJ fusion group who completed the 6 months follow-up.
Clinical Data to Date The INSITE study is the first and only published Level 1 randomized controlled trial to have compared SIJ fusion with nonsurgical treatment. Although this study demonstrated prolonged improvement in pain, disability and quality of life with SIJ fusion, superiority of SIJ fusion compared to nonsurgical treatment at 6 months cannot be generalized. This superiority trial may not have been truly clinically relevant because there was no specific treatment protocol used in the nonsurgical group for each subject. Nonsurgical management consisted of physical therapy in 98%, at least one steroid injection in 74%, 2 steroid injections in 4% and radiofrequency ablation of the sacral nerve root lateral branches in 46% of the 46 subjects assigned to nonsurgical treatment. The different proportions of treatment offered in the nonsurgical group may in fact differ from other pain management clinical practices and the generalizability of the results is questionable.
Compared to all nonsurgical treatment available for SIJ pain, the effectiveness of radiofrequency ablation is supported by literature of higher level of evidence. Prolonged therapeutic effect up to 6 months after the procedure has been demonstrated for radiofrequency ablation. In the INSITE study, only 21 subjects received radio frequency ablation, a group size that corresponds to only 21% of the number of subjects studied for SIJ fusion. This may explain why the nonsurgical group only had 26.1% success rate in this trial. The quality of evidence for the INSITE study may also be contested as the study sponsor, SI-BONE®, participated in the manuscript redaction and performed the statistical analysis.
The costs of nonsurgical treatments for SIJ pain are substantial in the United Sates medicare population and there is a need to assess the best cost effective therapy for SI joint pain. SIJ fusion and RFN are two SIJ pain treatment modalities that have been studied with a higher level of evidence compared to other modalities, showing significant effectiveness lasting more than 6 months after each procedure. However the effectiveness and costs associated with these two different treatments have never been compared in a clinically relevant randomized trial.
Dose Rationale and Risk/Benefits
RISKS
General / Unforeseeable
The risks of receiving a SIJ fusion include but are not limited to:
* post-operative incisional pain or worsened pain due to muscle spams
* hematoma and/or surgical site infection (less likely)
* nerve damage that can cause paralysis, loss of sensation or pain (unlikely
* possible second intervention for revision or withdrawal of implants (unlikely)
The risks of receiving SIJ radiofrequency ablation include but are not limited to:
* Pain or discomfort around the area treated
* numbness of skin covering the area treated, worsened pain due to muscle spasm,
* permanent nerve pain (less likely)
* allergies or reactions to medications, infection and/or hematoma (less likely) 3rd degree burn (rare)
* Nerve damage due to trauma (rare)
Other risks that are not specifically related to SIJ fusion or SIJ radiofrequency ablation but may occur during any procedure include:
* cardiovascular and /or cerebrovascular events
* cardiac arrhythmia
* deep vein thrombosis
* pulmonary emboli
* pneumonia
* urinary tract infection
* skin abrasions
* coma or death
Radiation Risks
Fluoroscopy is an imaging technique that uses X-rays during the SIJ fusion or SIJ radiofrequency ablation. This form or ionizing radiation poses a potential for increasing the patient's risk of radiation-induced cancer. Radiations doses and exposure during the study are the same that would be used if the subjects were receiving the treatment outside of this study. Therefore, this study does not involve any additional radiation risk for the subjects.
Study Objectives
Primary objective: Determine clinical superiority between minimally invasive SIJ fusion and radiofrequency ablation in chronic SIJ dysfunction patients
Secondary Objectives: Compare cost-effectiveness between treatment groups
Study Design
General Design
* Randomized controlled trial where randomization is done by a random number generator. Even numbers will be directed to the SI joint procedure group and odd numbers will be directed to the radiofrequency ablation procedure.
* The enrolment uses a 1:1 ratio of SIJ fusion to radio frequency ablation
* The subjects and investigators are not blinded to treatment allocation
Subjects will have a detailed medical history and will complete these questionnaires
* SIJ pain rating using the Visual Analogue Scale (VAS)
* Oswestry Disability Index (ODI)
* Short Form-36 (SF-36)
All subjects will be evaluated at randomization and at follow-up visits scheduled at 1, 3, 6, 9, and 12 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Sacroiliac Joint Somatic Dysfunction
Sacroiliac; Spondylitis
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Study Population: Chronic SIJ dysfunction patients presenting at selected Ochsner Health System healthcare centers
Recruiting mode: Participation will be offered by the principal investigator or the sub-investigators during an outpatient visit in the neurosurgery or pain management clinic.
Recruiting mode: Participation will be offered by the principal investigator or the sub-investigators during an outpatient visit in the neurosurgery or pain management clinic.
Primary Study Purpose
TREATMENT
Blinding Strategy
SINGLE
Outcome Assessors
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sacroiliac joint fusion
The subject will receive a sacroiliac joint fusion
Group Type
ACTIVE_COMPARATOR
Sacroiliac joint fusion
Intervention Type
PROCEDURE
Minimally invasive SIJ fusion will be performed under general anesthesia with fluoroscopy. Using SI-LOK®, Sacroiliac Joint Fixation System, Globus Medical Inc. (Audubon, PA), this procedure involve placement of 2 to 3 implants across the SIJ to achieve stabilization and arthrodesis.
Sacroiliac radio frequency ablation
The subject will receive a sacroiliac joint radiofrequency ablation
Group Type
ACTIVE_COMPARATOR
Sacroiliac joint radiofrequency ablation
Intervention Type
PROCEDURE
Sacroiliac joint radio frequency ablation will be performed using either conventional or cooled radiofrequency ablation techniques aimed at the S1-S3 lateral branches and the L5 dorsal ramus. The choice between conventional or cooled RFN will be determined by the provider expertise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sacroiliac joint fusion
Minimally invasive SIJ fusion will be performed under general anesthesia with fluoroscopy. Using SI-LOK®, Sacroiliac Joint Fixation System, Globus Medical Inc. (Audubon, PA), this procedure involve placement of 2 to 3 implants across the SIJ to achieve stabilization and arthrodesis.
Intervention Type
PROCEDURE
Sacroiliac joint radiofrequency ablation
Sacroiliac joint radio frequency ablation will be performed using either conventional or cooled radiofrequency ablation techniques aimed at the S1-S3 lateral branches and the L5 dorsal ramus. The choice between conventional or cooled RFN will be determined by the provider expertise.
Intervention Type
PROCEDURE
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Minimally invasive sacroiliac joint arthrodesis
Sacroiliac joint neurotomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female
* Age ≥ 18 years old
* Subject is willing and able to give informed consent for participation in the study
* Unilateral or bilateral SIJ pain for more than 50 days
* Persistent SIJ pain despite a trial of physical therapy for SI joint pain
* Agreement to avoid conception during trial
* Average VAS of at least 50 mm
* Minimal ODI score of at least 40%
* Etiology of SIJ dysfunction: osteoarthritis, past surgical history of lumbar or lumbosacral fusion, traumatic injury, post-partum.
* The SIJ pain can not be explained by a lumbar spine pathology seen on MRI: (disc herniation, lateral recess stenosis, moderate or severe spinal stenosis, synovial cyst, mass)
* Successful SIJ injection based on criteria discussed in recruitment section
* Age ≥ 18 years old
* Subject is willing and able to give informed consent for participation in the study
* Unilateral or bilateral SIJ pain for more than 50 days
* Persistent SIJ pain despite a trial of physical therapy for SI joint pain
* Agreement to avoid conception during trial
* Average VAS of at least 50 mm
* Minimal ODI score of at least 40%
* Etiology of SIJ dysfunction: osteoarthritis, past surgical history of lumbar or lumbosacral fusion, traumatic injury, post-partum.
* The SIJ pain can not be explained by a lumbar spine pathology seen on MRI: (disc herniation, lateral recess stenosis, moderate or severe spinal stenosis, synovial cyst, mass)
* Successful SIJ injection based on criteria discussed in recruitment section
Exclusion Criteria
* Sacroiliac joint injection will be done without any analgesics but anti anxiety medication can be used on case by case based
* The subject will attend a follow-up visit at 6 weeks after the SIJ block and steroid injection. During this visit if the subject's VAS has recurred to at least 50mm the patient will be randomized in either sacroiliac joint fusion or radiofrequency ablation.
* Subjects with VAS smaller than 50mm will be seen at 12 weeks of follow-up. During this visit if the subject's VAS has recurred to at least 50mm the patient will be randomized in either sacroiliac joint fusion or radiofrequency ablation. Subjects with smaller that 50mm VAS will be excluded from randomization at this time point.
* Neurological deficit
* History of cancer
* Active spinal or systemic infection
* Past medical history or active psychiatric condition
* Prohibited drug use
* Subject with pacemaker
* Pregnancy or Breastfeeding
* The subject will attend a follow-up visit at 6 weeks after the SIJ block and steroid injection. During this visit if the subject's VAS has recurred to at least 50mm the patient will be randomized in either sacroiliac joint fusion or radiofrequency ablation.
* Subjects with VAS smaller than 50mm will be seen at 12 weeks of follow-up. During this visit if the subject's VAS has recurred to at least 50mm the patient will be randomized in either sacroiliac joint fusion or radiofrequency ablation. Subjects with smaller that 50mm VAS will be excluded from randomization at this time point.
* Neurological deficit
* History of cancer
* Active spinal or systemic infection
* Past medical history or active psychiatric condition
* Prohibited drug use
* Subject with pacemaker
* Pregnancy or Breastfeeding
Minimum Eligible Age
18 Years
Maximum Eligible Age
100 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Globus Medical Inc
INDUSTRY
Sponsor Role
collaborator
Ochsner Health System
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Denis
Neurosurgeon staff at Ochsner Medical Center and Clinical Assistant Professor, Dept. Neurosurgery, Tulane University School of Medicine
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel R Denis, MD-MSc
Role: PRINCIPAL_INVESTIGATOR
Ochsner Health System
References
Explore related publications, articles, or registry entries linked to this study.
Maigne JY, Aivaliklis A, Pfefer F. Results of sacroiliac joint double block and value of sacroiliac pain provocation tests in 54 patients with low back pain. Spine (Phila Pa 1976). 1996 Aug 15;21(16):1889-92. doi: 10.1097/00007632-199608150-00012.
Reference Type
BACKGROUND
Schwarzer AC, Aprill CN, Bogduk N. The sacroiliac joint in chronic low back pain. Spine (Phila Pa 1976). 1995 Jan 1;20(1):31-7. doi: 10.1097/00007632-199501000-00007.
Reference Type
BACKGROUND
Sembrano JN, Polly DW Jr. How often is low back pain not coming from the back? Spine (Phila Pa 1976). 2009 Jan 1;34(1):E27-32. doi: 10.1097/BRS.0b013e31818b8882.
Reference Type
BACKGROUND
Borowsky CD, Fagen G. Sources of sacroiliac region pain: insights gained from a study comparing standard intra-articular injection with a technique combining intra- and peri-articular injection. Arch Phys Med Rehabil. 2008 Nov;89(11):2048-56. doi: 10.1016/j.apmr.2008.06.006.
Reference Type
BACKGROUND
Capobianco R, Cher D; SIFI Study Group. Safety and effectiveness of minimally invasive sacroiliac joint fusion in women with persistent post-partum posterior pelvic girdle pain: 12-month outcomes from a prospective, multi-center trial. Springerplus. 2015 Oct 5;4:570. doi: 10.1186/s40064-015-1359-y. eCollection 2015.
Reference Type
BACKGROUND
Longo UG, Loppini M, Berton A, Laverde L, Maffulli N, Denaro V. Degenerative changes of the sacroiliac joint after spinal fusion: an evidence-based systematic review. Br Med Bull. 2014 Dec;112(1):47-56. doi: 10.1093/bmb/ldu030. Epub 2014 Oct 29.
Reference Type
BACKGROUND
Unoki E, Abe E, Murai H, Kobayashi T, Abe T. Fusion of Multiple Segments Can Increase the Incidence of Sacroiliac Joint Pain After Lumbar or Lumbosacral Fusion. Spine (Phila Pa 1976). 2016 Jun;41(12):999-1005. doi: 10.1097/BRS.0000000000001409.
Reference Type
BACKGROUND
Kok HK, Mumtaz A, O'Brien C, Kane D, Torreggiani WC, Delaney H. Imaging the Patient With Sacroiliac Pain. Can Assoc Radiol J. 2016 Feb;67(1):41-51. doi: 10.1016/j.carj.2015.08.001. Epub 2015 Nov 26.
Reference Type
BACKGROUND
Irwin RW, Watson T, Minick RP, Ambrosius WT. Age, body mass index, and gender differences in sacroiliac joint pathology. Am J Phys Med Rehabil. 2007 Jan;86(1):37-44. doi: 10.1097/phm.0b013e31802b8554.
Reference Type
BACKGROUND
Simopoulos TT, Manchikanti L, Gupta S, Aydin SM, Kim CH, Solanki D, Nampiaparampil DE, Singh V, Staats PS, Hirsch JA. Systematic Review of the Diagnostic Accuracy and Therapeutic Effectiveness of Sacroiliac Joint Interventions. Pain Physician. 2015 Sep-Oct;18(5):E713-56.
Reference Type
BACKGROUND
Szadek KM, van der Wurff P, van Tulder MW, Zuurmond WW, Perez RS. Diagnostic validity of criteria for sacroiliac joint pain: a systematic review. J Pain. 2009 Apr;10(4):354-68. doi: 10.1016/j.jpain.2008.09.014. Epub 2008 Dec 19.
Reference Type
BACKGROUND
Hungerford B, Gilleard W, Hodges P. Evidence of altered lumbopelvic muscle recruitment in the presence of sacroiliac joint pain. Spine (Phila Pa 1976). 2003 Jul 15;28(14):1593-600.
Reference Type
BACKGROUND
O'Sullivan PB, Beales DJ, Beetham JA, Cripps J, Graf F, Lin IB, Tucker B, Avery A. Altered motor control strategies in subjects with sacroiliac joint pain during the active straight-leg-raise test. Spine (Phila Pa 1976). 2002 Jan 1;27(1):E1-8. doi: 10.1097/00007632-200201010-00015.
Reference Type
BACKGROUND
Cohen SP, Hurley RW, Buckenmaier CC 3rd, Kurihara C, Morlando B, Dragovich A. Randomized placebo-controlled study evaluating lateral branch radiofrequency denervation for sacroiliac joint pain. Anesthesiology. 2008 Aug;109(2):279-88. doi: 10.1097/ALN.0b013e31817f4c7c.
Reference Type
BACKGROUND
Patel N, Gross A, Brown L, Gekht G. A randomized, placebo-controlled study to assess the efficacy of lateral branch neurotomy for chronic sacroiliac joint pain. Pain Med. 2012 Mar;13(3):383-98. doi: 10.1111/j.1526-4637.2012.01328.x. Epub 2012 Feb 2.
Reference Type
BACKGROUND
Cheng J, Pope JE, Dalton JE, Cheng O, Bensitel A. Comparative outcomes of cooled versus traditional radiofrequency ablation of the lateral branches for sacroiliac joint pain. Clin J Pain. 2013 Feb;29(2):132-7. doi: 10.1097/AJP.0b013e3182490a17.
Reference Type
BACKGROUND
Duhon BS, Cher DJ, Wine KD, Kovalsky DA, Lockstadt H; SIFI Study Group. Triangular Titanium Implants for Minimally Invasive Sacroiliac Joint Fusion: A Prospective Study. Global Spine J. 2016 May;6(3):257-69. doi: 10.1055/s-0035-1562912. Epub 2015 Aug 11.
Reference Type
BACKGROUND
Polly DW, Cher DJ, Wine KD, Whang PG, Frank CJ, Harvey CF, Lockstadt H, Glaser JA, Limoni RP, Sembrano JN; INSITE Study Group. Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion Using Triangular Titanium Implants vs Nonsurgical Management for Sacroiliac Joint Dysfunction: 12-Month Outcomes. Neurosurgery. 2015 Nov;77(5):674-90; discussion 690-1. doi: 10.1227/NEU.0000000000000988.
Reference Type
BACKGROUND
Whang P, Cher D, Polly D, Frank C, Lockstadt H, Glaser J, Limoni R, Sembrano J. Sacroiliac Joint Fusion Using Triangular Titanium Implants vs. Non-Surgical Management: Six-Month Outcomes from a Prospective Randomized Controlled Trial. Int J Spine Surg. 2015 Mar 5;9:6. doi: 10.14444/2006. eCollection 2015.
Reference Type
BACKGROUND
Ackerman SJ, Polly DW Jr, Knight T, Schneider K, Holt T, Cummings J. Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States Medicare population: potential economic implications of a new minimally-invasive technology. Clinicoecon Outcomes Res. 2013 Nov 20;5:575-87. doi: 10.2147/CEOR.S52967. eCollection 2013.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
X-99
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Clinical Outcome and Fusion Results Using the SiJoin® Transfixing Sacroiliac Fusion Device
NCT05712850
UNKNOWN
SI Joint Stabilization in Long Fusion to the Pelvis
NCT04062630
COMPLETED
NA
RFA Using Multi-Tined Electrodes vs.Traditional Electrodes for Lumbar Spondylosis
NCT06477094
RECRUITING
NA
A Prospective Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves Versus Facet Joint Injection of Corticosteroid for the Treatment of Lumbar Facet Syndrome
NCT03614793
COMPLETED
NA
iFuse Implant System® Minimally Invasive Arthrodesis
NCT01741025
COMPLETED
NA
Fluoroscopically-guided Versus Landmark-guided Sacroiliac Joint Injections
NCT02096653
COMPLETED
NA
SAIF: Sacroiliac Fusion Study
NCT02064322
TERMINATED
LUMBAR & SACROILIAC FUSION STUDY
NCT07204288
RECRUITING
NA
Steroid Versus Platelet Rich Plasma Injection for Chronic Low Back Pain
NCT02334475
COMPLETED
NA
SI Joint Fusion and Decortication Using the SImmetry System
NCT02560714
TERMINATED
Medial Branch Radiofrequency Ablation and Lumbar Multifidi
NCT03744260
COMPLETED
Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System
NCT02074761
UNKNOWN
Primary Sacroiliac Fusion Versus Fusion to the Sacrum for Degenerative Disease of the Lumbar Spine
NCT04308018
UNKNOWN
NA
LOIS: Long-Term Follow-Up in INSITE/SIFI
NCT02270203
COMPLETED
Safety of Spine Radiofrequency Procedures
NCT02210052
COMPLETED
NA
Safety And Efficacy Assessment of the zLock Facet Fusion System- A Pilot Study
NCT04229316
COMPLETED
NA
MRgFUS and RFA for Treatment of Facet-joint Osteoarthritis Low Back Pain
NCT03168802
RECRUITING
NA
Spinal Stimulation to Treat Low Back Pain
NCT02128672
WITHDRAWN
NA
Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion
NCT03327272
WITHDRAWN
PHASE3
Comparison Between Platelet-rich Fibrin and Steroid for Intra-articular Injection for Sacroiliac Joint Dysfunction
NCT04757740
COMPLETED
PHASE4
"Is Instrumentation Necessary for "Static" Degenerative Spondylolisthesis"
NCT02530775
WITHDRAWN
NA
Synvisc Injections for Lumbar Facet Joint Pain
NCT00325845
UNKNOWN
PHASE3
Medial Branch Blocks vs. Intra-articular Injections: Randomized, Controlled Study
NCT02002429
COMPLETED
NA
Study to Evaluate Safety and Effectiveness of Spinal Sealant
NCT00594035
COMPLETED
NA